Real World Assessment of People Living With Chronic Hepatitis B in Australia (REACH-B)

Kirby Institute

Status: Enrolling

Conditions: Hepatitis B

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT04914611

VHCRP2008

Details and patient eligibility

About

The REACH-B study establishes an observational cohort study of people living with chronic hepatitis B from a national network, including a diverse range of services, to characterise and monitor hepatitis B linkage to care and treatment requirements amongst this population.

Full description

Participants presenting to participating clinics for HBV care within the previous 12 months will be identified and enrolment data will be collected including demographics, laboratory parameters, liver disease assessment, treatment history and clinical management. Follow-up data on HBV treatment and clinical management, liver disease stage and laboratory parameters will be collected at each subsequent visit or at minimum every 12 months.

Enrollment: 10,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. All individuals diagnosed with chronic hepatitis B in the participating study sites are eligible to be included (both newly diagnosed cases and those diagnosed in the past).
2. 16 years of age or older.
3. Attended the health service for HBV care within the prior 12 months from study commencement (retrospective recruitment) OR Attending the health service for HBV care from study commencement (prospective recruitment)

Exclusion criteria

1. Nil

Trial design

10,000 participants in 1 patient group

HBsAg Positive

Description:

Patients with chronic hepatitis B infection as defined by HBV surface antigen positive

Treatment:

Other: No intervention